System Transmission

Top Signal

100#1 JOB

Activity

2180Ripe

+936 today

System

Livenow

Terminal Asset View

stockNASDAQ

MREO

$0.39-0.23%

Mereo Biopharma Group Plc

Ripening

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

64Ripening

Live Analysis Active

Company Mission

Mereo Biopharma creates treatments for rare diseases and cancer. Doctors and hospitals use these medicines to help patients with serious health conditions. The company makes money by partnering with larger drug companies and potentially selling approved drugs.

MRE

Industry Context

The biopharmaceutical industry focuses on developing treatments for serious medical conditions. Companies in this space often work on drugs for rare diseases or cancer, which can take many years of research and testing. Success depends on clinical trial results and regulatory approvals.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

78Matrix

Market Momentum

35.2— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.7x— Normal Volume

Today's Change

-0.23%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing MREO across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:00 AM UTC

As-of 03-15-2026 06:45 UTC

Develops new medicines for rare diseases and cancers, earning money by selling approved drugs and partnering with larger pharmaceutical companies.

Price below key moving averages, suggesting a downtrend where sellers have been in control recently showing consolidation pattern.

Technical squeeze detected near current levels, indicating potential for a breakout move as price compresses over the past few weeks, suggesting.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...